An inherited deficiency of adenosine deaminase (ADA) is an ultrarare metabolic disorder (one in 0.2–1 million newborns) resulting in the accumulation of toxic purine metabolites, especially deoxyadenosine triphosphate (dATP).1, 2. This evidence concerns the gene ADA and metabolic disease.